Price Capital Management’s Merck MRK Stock Holding History

Price Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,216	Closed	-$1.5M	–	29
2018 Q3	$1.5M	Buy	+22,216	New	+$1.42M	0.53%	16

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Price Capital Management's MRK Position: Q4 2018 in Review

Price Capital Management sold out of Merck (MRK) in Q4 2018, closing a stake of 22,216 shares — an estimated $1.5M sold.

Price Capital Management first reported a position in MRK in Q3 2018 and held it in 1 quarter. The position peaked at $1.5M in Q3 2018. 2,251 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

Price Capital Management reported no remaining Merck position as of Q4 2018 after selling out during the quarter.
Price Capital Management sold 22,216 Merck shares in Q4 2018, an estimated $1.5M.
Price Capital Management first reported a position in Merck in Q3 2018 and held it in 1 quarter.
Price Capital Management's Merck position peaked at $1.5M in Q3 2018.
2,251 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Price Capital Management's 13F filing for Q4 2018, filed 15 Jan 2019.